Cephalon’s Treanda Approved For Indolent Non-Hodgkin’s Lymphoma
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm says convenient dosing schedule is a plus for the drug, though it will be combined – not competing – with other NHL chemotherapy agents.